NexPoint Diversified Real Estate Trust (NYSE:NXDT – Get Free Report) insider James D. Dondero purchased 2,081 shares of the firm’s stock in a transaction that occurred on Thursday, October 5th. The shares were acquired at an average cost of 14.20 per share, with a total value of 29,550.20. Following the completion of the purchase, the […]
StockNews.com lowered shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a buy rating to a hold rating in a report published on Wednesday. A number of other equities analysts have also recently commented on PRTK. Jefferies Financial Group cut shares of Paratek Pharmaceuticals from a buy rating to a hold rating in a research […]
NexPoint Diversified Real Estate Trust (NYSE:NXDT – Get Rating) declared a quarterly dividend on Wednesday, April 26th, Zacks reports. Shareholders of record on Thursday, June 15th will be paid a dividend of 0.15 per share on Friday, June 30th. This represents a $0.60 dividend on an annualized basis and a yield of 5.13%. The ex-dividend […]
HC Wainwright lowered shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a buy rating to a neutral rating in a research note released on Wednesday morning, The Fly reports. Several other equities analysts have also recently commented on the stock. BTIG Research decreased their price target on shares of Paratek Pharmaceuticals from $24.00 to […]
StockNews.com upgraded shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a hold rating to a buy rating in a report published on Tuesday. A number of other equities research analysts have also commented on PRTK. BTIG Research reduced their price target on Paratek Pharmaceuticals from $24.00 to $5.00 in a research report on Tuesday, […]